Olorofim

Olorofim
Clinical data
Other namesF901318
Legal status
Legal status
  • Investigational
Identifiers
  • 2-(1,5-Dimethyl-3-phenylpyrrol-2-yl)-N-[4-[4-(5-fluoropyrimidin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide
CAS Number
PubChem CID
UNII
Chemical and physical data
FormulaC28H27FN6O2
Molar mass498.562 g·mol−1

Olorofim (F901318) is an experimental antifungal drug being developed for invasive mold infections. If approved it would be a first-in-class medication (for the orotomide class). In 2023, the FDA decided not to approve the drug and to request more data about the safety of the drug. Olorofim does not inhibit growth of Candida species.